» Articles » PMID: 30219540

Increased Risk of Myocardial Infarction with Dabigatran Etexilate: Fact or Fiction? A Critical Meta-analysis from Integrating Randomized Controlled Trials and Real-world Studies: Wine or Spritzer?

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2018 Sep 17
PMID 30219540
Citations 3
Authors
Affiliations
Soon will be listed here.
Citing Articles

Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Myocardial Infarction in Patients with Atrial Fibrillation with or without Percutaneous Coronary Interventions: A Meta-Analysis.

Grajek S, Kaluzna-Oleksy M, Siller-Matula J, Grajek M, Michalak M J Pers Med. 2021; 11(10).

PMID: 34683155 PMC: 8539187. DOI: 10.3390/jpm11101013.


Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis.

Zhou Y, Yao Z, Zhu L, Tang Y, Chen J, Wu J Front Pharmacol. 2021; 12:626063.

PMID: 33633574 PMC: 7901998. DOI: 10.3389/fphar.2021.626063.


Net Clinical Benefit of Direct Oral Anticoagulants in Patients With Cancer and Venous Thromboembolism: A Systematic Review and Trade-Off Analysis.

Yan Y, Ding Z, Pan M, Xia Q, Cui J, Wang L Front Cardiovasc Med. 2020; 7:586020.

PMID: 33304929 PMC: 7693545. DOI: 10.3389/fcvm.2020.586020.